| Revenue growth | Q2 -23% YoY, +62% QoQ; H1 -32% YoY |
|---|---|
| Margins | EBITDA margin 16.9% vs 31.7% YoY; 23.3% in Q1 |
| Demand visibility | Europe demand subdued; domestic focus; European traction improving |
| Management confidence | Expects core business recovery over next few quarters |
Growth
Q2 revenue -23% YoY but +62% QoQ; H1 revenue ₹37.65 Cr (-32% YoY). PAT down 67% YoY in both Q2 and H1.
Outlook
Management expects input costs to ease and margins to normalise as volumes recover; no numeric guidance given. SE Asia specialty supplies from Q1FY28; Plant 7 capex ~₹20 Cr.
Risks
Subdued Europe demand, volumes below prior levels, and volatile raw material prices compressing margins; EBITDA margin down 1,483 bps YoY.
Investor Presentation filed with BSE, NSE: SGRL. Summary written with AI assistance from the document.
Shree Ganesh Remedies Ltd: key numbers
- Share price
- ₹617.00
- Market cap
- ₹792.1 Cr
- Revenue (annual)
- ₹109.3 Cr
- Net profit (annual)
- ₹17.76 Cr
- P/E (TTM)
- 51.3×Sector 45.9×
- Promoter holding
- 72.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Remedies Ltd
All →Shree Ganesh Remedies Results Update
Shree Ganesh Remedies released a press release on Q2 and H1 FY27 unaudited results, with Q2 revenue of ₹23.29 Crore, down 23% year-on-year. PAT fell 67% to ₹1.63 Crore.
Shree Ganesh Remedies Q2 FY27 Results: Net Profit ₹1.6 Cr, Down 68.0% YoY
Shree Ganesh Remedies' board approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Revenue from operations for the half year was Rs 3,765.47 lakhs, down from Rs 5,498.29 lakhs a year earlier.
- Key figure
- Net profit ₹1.6 Cr · -68.0% YoY
Shree Ganesh Remedies Board Meeting Date
Shree Ganesh Remedies Ltd notified BSE of a board meeting on October 31, 2026, to consider unaudited standalone and consolidated results for the quarter ended September 2026. Trading window remains closed until 48 hours after the results declaration.
Shree Ganesh Remedies Other Announcement
Shree Ganesh Remedies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Shree Ganesh Remedies Management Change
Shree Ganesh Remedies Ltd has announced the resignation of Mr. Aditya Vikrambhai Patel as Company Secretary and the appointment of Ms. Akanksha as his successor.
Shree Ganesh Remedies Annual General Meeting
Shree Ganesh Remedies held its 31st Annual General Meeting on September 12, 2026. The meeting transacted ordinary and special business items, including director and auditor appointments.